Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

Journal of Clinical Oncology

Volumn 26, Issue 21, 2008, Pages 3496-3502

  Evans, Douglas B ^a   Varadhachary, Gauri R ^a   Crane, Christopher H ^a   Sun, Charlotte C ^a   Lee, Jeffrey E ^a   Pisters, Peter W T ^a   Vauthey, Jean Nicolas ^a   Wang, Huamin ^a   Cleary, Karen R ^a   Staerkel, Gregg A ^a   Charnsangavej, Chusilp ^a   Lano, Elizabeth A ^a   Ho, Linus ^a   Lenzi, Renato ^a   Abbruzzese, James L ^a   Wolff, Robert A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ABDOMINAL PAIN; ANEMIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEHYDRATION; DIARRHEA; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; ENTERITIS; FAILURE TO THRIVE; FATIGUE; FEBRILE NEUTROPENIA; GRANULOCYTOPENIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; NAUSEA; OCCLUSION; PAIN; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PANCREATOGRAPHY; PHASE 2 CLINICAL TRIAL; PREOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; DISEASE FREE SURVIVAL; FEMALE; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT;

EID: 49049101358     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.8634     Document Type: Article

References (27)

1. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer: Gastrointestinal Tumor Study Group. Cancer 59:2006-2010, 1987
2. Neoptolemos JP, Stocken DD, Friess H, et al: European Study Group for Pancreatic Cancer: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210, 2004
3. Oettle H, Post S, Neuhaus P, et al: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 297:267-277, 2007
4. Crane CH, Varadhachary G, Wolff RA, et al: The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. Best Pract Res Clin Gastroenterol 20:365-382, 2006
5. Spitz FR, Abbruzzese JL, Lee JE, et al: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15:928-937, 1997
6. Evans DB, Rich TA, Byrd DR, et al: Preoperative chemoradiation and PD for adenocarcinoma of the pancreas. Arch Surg 127:1335-1339, 1992
7. Pisters PWT, Abbruzzese JL, Janjan NA, et al: Rapid-fractionation preoperative chemoradiation, PD, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma J Clin Oncol 16: 3843-3850, 1998
8. Pisters PWT, Wolff RA, Janjan NA, et al: Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: Toxicities, histologic response rates, and event-free outcome. J Clin Oncol 20:2537-2544, 2002
9. Burris HA, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15:2403-2413, 1997
10. Wolff RA, Evans DB, Gravel DM, et al: Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res 7:2246-2253, 2001
11. Raut CP, Grau AM, Staerkel GA, et al: Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 7:118-128, 2003; discussion 127-128
12. Evans DB, Lee JE, Tamm EP, et al: Pancreaticoduodenectomy (Whipple Operation) and total pancreatectomy for cancer, in Fischer JF (ed): Mastery of Surgery (ed 5). Philadelphia, PA, Lippincott Williams & Wilkins, 2007, pp 1299-1317
13. Yen TWF, Abdalla EK, Pisters PWT, et al: Pancreaticoduodenectomy, in VonHoff DD, Evans DB, Hruban RH (eds): Pancreatic Cancer. Sudbury, MA, Jones and Bartlett Publishers, 2005, pp 265-285
14. Tseng JF, Raut CP, Lee JE, et al: PD with vascular resection: Margin status and survival duration. J Gastrointest Surg 8:935-950, 2004; discussion 949-950
15. Pisters PWT, Hudec WA, Hess KR, et al: Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234:47-55, 2001
16. Staley CA, Cleary KA, Abbruzzese JA, et al: Need for standardized pathologic staging of PD specimens. Pancreas 12:373-380, 1996
17. Exocrine pancreas, in Greene FL, Page DL, Fleming ID, et al (eds): AJCC Cancer Staging Manual. Chicago, IL, AJCC, 2002, pp 157-164
18. Raut CP, Tseng JF, Sun CC, et al: Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52-60, 2007
19. Mullen JT, Lee JH, Gomez HF, et al: PD after placement of endobiliary metal stents. J Gastrointest Surg 9:1094-1104, 2005
20. Hoffman JP, McGinn C, Szarka J, et al: A phase I study of preoperative gemcitabine (GEM) with radiation therapy (RT) followed by postoperative GEM for patients with localized, resectable pancreatic adenocarcinoma (PAC). Proc Am Soc Clin Oncol 17:283a, 1998 (abstr 1090)
21. Joensuu TK, Kiviluoto T, Karkkainen P, et al: Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 60:444-452, 2004
22. Talamonti MS, Small W Jr, Mulcahy MF, et al: A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 13:150-158, 2006
23. Palmer DH, Stocken DD, Hewitt H, et al: A randomized phase 2 trial of neoadjuvant chemotherapy in respectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 14:2088-2096, 2007
24. Crane CH, Wolff RA, Abbruzzese JL, et al: Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index. Semin Oncol 28:25-33, 2001
25. Lowy AM, Lee JE, Pisters PWT, et al: Prospective, randomized trial of octreotide to prevent pancreatic fistula following pancreaticoduodenectomy for malignant disease. Ann Surg 226:632-641, 1997
26. Chen VK, Arguedas MR, Baron TH: Expandable metal biliary stents before pancreaticoduodenectomy for pancreatic cancer: A Monte-Carlo decision analysis. Clin Gastroenterol Hepatol 3:1229-1237, 2005
27. Varadhachary GR, Wolff RA, Crane CH, et al: Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26:3487-3495, 2008